Novel Oral Trojan-Horse Agents for Osteolytic Cancer

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43CA109801-01
Agency Tracking Number: CA109801
Amount: $546,002.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solitcitation Year: 2004
Solitcitation Topic Code: N/A
Solitcitation Number: PHS2004-2
Small Business Information
SYNTRIX BIOSYSTEMS, INC.
SYNTRIX BIOSYSTEMS, INC., 215 CLAY ST NW, STE B-5, AUBURN, WA, 98001
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 ALEX Goldstein
 (253) 833-8009
 AGOLDSTEIN@SYNTRIXBIO.COM
Business Contact
Phone: (253) 833-8009
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The bisphosphonates have emerged as powerful new weapons in the therapeutic arsenal employed to treat bone metastases and cancer osteolysis. These metabolically stable pyrophosphate mimetics incorporate in bone and i

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government